ELI LILLY AND COMPANY revenue for the last year amounted to 579.60 B MXN, the most of which — 579.60 B MXN — came from its highest performing source at the moment, Human Pharmaceutical Products, the year earlier bringing 556.69 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought ELI LILLY AND COMPANY 370.12 B MXN, and the year before that — 354.79 B MXN.